MSc, Product Manager, GenScript USA Inc.
BIOGRAPHY
NOV 29, 2022 10:00 AM PST
How to Accelerate Western Blotting While Maintaining Industry Standard Quality
Speaker
Event Date & Time
Date: November 29, 2022
Time: 10:00am (PST), 1:00pm (EST), 7:00pm (CET)
Abstract
Western blotting is a commonly used analytical technique in protein analysis. However, the standard manual workflow from protein separation to detection is time-consuming and sometimes highly involved for researchers. In order to improve the workflow efficiency and data reproducibility, GenScript has developed a suite of innovative and customizable instrument-based solutions, namely eStain™, eBlot™, and eZwest™, that deliver western blot results consistently and quickly.
Learning Objectives
- Benefits and limitations of the current western blotting methodologies
- What are the optimal solutions to maximize the efficiency of western blotting while maintaining industry standard quality
- Demonstration of the data consistency using the GenScript solutions for western blotting
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
MAR 26, 2024 | 7:00 PM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
MAR 26, 2024 | 8:00 AM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
MAR 26, 2024 | 11:00 AM
Ever wonder what you’re missing in your data? The sheer complexity of today’s flow and mass cytometry datasets demands automated solutions. Machine learning plugins only provide...
DEC 12, 2023 15:00 CET
C.E. CREDITS
The implementation of the new CE-In Vitro Diagnostics Regulation (IVDR) involves challenges faced by labs that are working within the diagnostic environment. The aim of this event is to get...
NOV 29, 2023 | 9:00 AM
Tumor genomic profiling can be complicated, especially for diseases that commonly have multiple different genomic biomarkers of interest, such as non-small cell lung cancer (NSCLC) and color...
FEB 08, 2024 | 10:00 AM
High-content screening (HCS) is an imaging-based, multi-parametric strategy used in drug development that generates rich datasets through multiplexing strategically chosen fluorescent dyes a...
Loading Comments...
Finish Registering
-
APR 30, 2024Immuno-Oncology Virtual Event Series 2024 -
MAY 07, 20243rd International Biosecurity Virtual Symposium
-
JUN 06, 2024The Future of Scientific Conferencing
- See More
-
APR 25, 2024
- See More
